Correction to: Genetics in Medicine; https://doi.org/10.1038/gim.2018.31; published online 15 March 2018
The PDF and HTML versions of the article have been updated to include the Creative Commons Attribution 4.0 International License information.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Maruyama, H., Miyata, K., Mikame, M. et al. Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis. Genet Med 21, 1900 (2019). https://doi.org/10.1038/s41436-018-0258-3
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41436-018-0258-3
